{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:08:47Z","timestamp":1778396927910,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"DOI":"10.7759\/cureus.108574","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:32:57Z","timestamp":1778394777000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between Baseline Serum Testosterone Levels and Cognitive Gain Following Combined Oral Contraceptive Treatment in Patients With Polycystic Ovary Syndrome"],"prefix":"10.7759","author":[{"given":"Saloni","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheeba","family":"Marwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumen","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himani","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2021.100085","article-title":"A review: brief insight into polycystic ovarian syndrome","volume":"3","author":"Bulsara J","year":"2021","unstructured":"Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021, 3:100085. 10.1016\/j.endmts.2021.100085","journal-title":"Endocr Metab Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2016.1184","article-title":"Polycystic ovarian syndrome: clinical and biological diagnosis","volume":"74","author":"Bachelot A","year":"2016","unstructured":"Bachelot A. Polycystic ovarian syndrome: clinical and biological diagnosis. Ann Biol Clin (Paris). 2016, 74:661-7. 10.1684\/abc.2016.1184","journal-title":"Ann Biol Clin (Paris)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2024.030","article-title":"Pharmacological management of polycystic ovary syndrome","volume":"47","author":"Ee C","year":"2024","unstructured":"Ee C, Tay CT. Pharmacological management of polycystic ovary syndrome. Aust Prescr. 2024, 47:109-12. 10.18773\/austprescr.2024.030","journal-title":"Aust Prescr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.958","article-title":"An update on contraception in polycystic ovary syndrome","volume":"36","author":"Oguz SH","year":"2021","unstructured":"Oguz SH, Yildiz BO. An update on contraception in polycystic ovary syndrome. Endocrinol Metab (Seoul). 2021, 36:296-311. 10.3803\/EnM.2021.958","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0516","article-title":"Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial","volume":"177","author":"Alpa\u00f1\u00e9s M","year":"2017","unstructured":"Alpa\u00f1\u00e9s M, \u00c1lvarez-Blasco F, Fern\u00e1ndez-Dur\u00e1n E, Luque-Ram\u00edrez M, Escobar-Morreale HF. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial. Eur J Endocrinol. 2017, 177:399-408. 10.1530\/EJE-17-0516","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.22165","article-title":"Possible cognition changes in women with polycystic ovary syndrome: a narrative review","volume":"66","author":"Naz MS","year":"2023","unstructured":"Naz MS, Rahnemaei FA, Tehrani FR, Sayehmiri F, Ghasemi V, Banaei M, Ozgoli G. Possible cognition changes in women with polycystic ovary syndrome: a narrative review. Obstet Gynecol Sci. 2023, 66:347-63. 10.5468\/ogs.22165","journal-title":"Obstet Gynecol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208104","article-title":"Associations of polycystic ovary syndrome with indicators of brain health at midlife in the CARDIA Cohort","volume":"102","author":"Huddleston HG","year":"2024","unstructured":"Huddleston HG, Jaswa EG, Casaletto KB, et al.. Associations of polycystic ovary syndrome with indicators of brain health at midlife in the CARDIA Cohort. Neurology. 2024, 102:e208104. 10.1212\/WNL.0000000000208104","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13030-024-00320-w","article-title":"The impact of polycystic ovary syndrome on attention: an empirical investigation","volume":"19","author":"Redkar M","year":"2025","unstructured":"Redkar M, Khan A. The impact of polycystic ovary syndrome on attention: an empirical investigation. Biopsychosoc Med. 2025, 19:3. 10.1186\/s13030-024-00320-w","journal-title":"Biopsychosoc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2007.02.007","article-title":"Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women","volume":"51","author":"Schattmann L","year":"2007","unstructured":"Schattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav. 2007, 51:587-96. 10.1016\/j.yhbeh.2007.02.007","journal-title":"Horm Behav"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2007.02.002","article-title":"Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study","volume":"51","author":"Schattmann L","year":"2007","unstructured":"Schattmann L, Sherwin BB. Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study. Horm Behav. 2007, 51:579-86. 10.1016\/j.yhbeh.2007.02.002","journal-title":"Horm Behav"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.01.034","article-title":"Does polycystic ovary syndrome affect cognition? A functional magnetic resonance imaging study exploring working memory","volume":"105","author":"Soleman RS","year":"2016","unstructured":"Soleman RS, Kreukels BP, Veltman DJ, Cohen-Kettenis PT, Hompes PG, Drent ML, Lambalk CB. Does polycystic ovary syndrome affect cognition? A functional magnetic resonance imaging study exploring working memory. Fertil Steril. 2016, 105:1314-21.e1. 10.1016\/j.fertnstert.2016.01.034","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-025-01628-4","article-title":"Oral contraceptive treatment improves cognitive performance in polycystic ovarian syndrome (PCOS) patients","volume":"28","author":"Kumari S","year":"2025","unstructured":"Kumari S, Manna S, Marwah S, Ahluwalia H, Panwar S. Oral contraceptive treatment improves cognitive performance in polycystic ovarian syndrome (PCOS) patients. Arch Womens Ment Health. 2025, 28:1527-34. 10.1007\/s00737-025-01628-4","journal-title":"Arch Womens Ment Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM\u2010sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM\u2010sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-7. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2007.06.010","article-title":"Cognitive functioning in polycystic ovary syndrome","volume":"32","author":"Barnard L","year":"2007","unstructured":"Barnard L, Balen AH, Ferriday D, Tiplady B, Dye L. Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology. 2007, 32:906-14. 10.1016\/j.psyneuen.2007.06.010","journal-title":"Psychoneuroendocrinology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2017.10.019","article-title":"An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome (PCOS)","volume":"110","author":"Barry JA","year":"2018","unstructured":"Barry JA, Qu F, Hardiman PJ. An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome (PCOS). Med Hypotheses. 2018, 110:42-5. 10.1016\/j.mehy.2017.10.019","journal-title":"Med Hypotheses"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.4158","article-title":"Non-contraceptive benefits of oral hormonal contraceptives","volume":"11","author":"Schindler AE","year":"2013","unstructured":"Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab. 2013, 11:41-7. 10.5812\/ijem.4158","journal-title":"Int J Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1586\/eem.10.88","article-title":"Oral contraceptives in polycystic ovarian syndrome: the long and short of it","volume":"6","author":"Nader S","year":"2011","unstructured":"Nader S. Oral contraceptives in polycystic ovarian syndrome: the long and short of it. Expert Rev Endocrinol Metab. 2011, 6:129-33. 10.1586\/eem.10.88","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.03.081","article-title":"Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions","volume":"94","author":"Farrell K","year":"2010","unstructured":"Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010, 94:1565-74. 10.1016\/j.fertnstert.2010.03.081","journal-title":"Fertil Steril"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30351","article-title":"Insulin resistance in polycystic ovarian syndrome","volume":"14","author":"Purwar A","year":"2022","unstructured":"Purwar A, Nagpure S. Insulin resistance in polycystic ovarian syndrome. Cureus. 2022, 14:e30351. 10.7759\/cureus.30351","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann S","year":"2016","unstructured":"Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, H\u00e4ring HU. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev. 2016, 96:1169-209. 10.1152\/physrev.00032.2015","journal-title":"Physiol Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18013","article-title":"Insulin resistance, hyperandrogenism, and its associated symptoms are the precipitating factors for depression in women with polycystic ovarian syndrome","volume":"13","author":"Ethirajulu A","year":"2021","unstructured":"Ethirajulu A, Alkasabera A, Onyali CB, Anim-Koranteng C, Shah HE, Bhawnani N, Mostafa JA. Insulin resistance, hyperandrogenism, and its associated symptoms are the precipitating factors for depression in women with polycystic ovarian syndrome. Cureus. 2021, 13:e18013. 10.7759\/cureus.18013","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488683-correlation-between-baseline-serum-testosterone-levels-and-cognitive-gain-following-combined-oral-contraceptive-treatment-in-patients-with-polycystic-ovary-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:32:58Z","timestamp":1778394778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488683-correlation-between-baseline-serum-testosterone-levels-and-cognitive-gain-following-combined-oral-contraceptive-treatment-in-patients-with-polycystic-ovary-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.108574","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}